Precision Oncology Market Size, Share & Industry Analysis, By Type (Diagnostics {Companion Diagnostics, Comprehensive Genomic Profiling, Liquid Biopsy Assays, Single Biomarker Tests, and Others} and Therapeutics {Targeted Therapies, Biomarker-Guided Immunotherapies, and Others}), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Hematologic Malignancies, and Others), By End User (Hospitals & Cancer Centres, Diagnostic Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others), and Regional Forecast, 2026-2034

Last Updated: May 07, 2026 | Format: PDF | Report ID: FBI116082

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Challenges
4. Market Opportunities
5. Market Trends
Key Insights
1. Technological Advancements in Precision Oncology
2. Regulatory Scenario, By Key Countries/Region
3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
4. New Product Launches, By Key Players
Global Precision Oncology Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Diagnostics
    1. Companion Diagnostics
    2. Comprehensive Genomic Profiling
    3. Liquid Biopsy Assays
    4. Single Biomarker Tests
    5. Others
  2. Therapeutics
    1. Targeted Therapies
    2. Biomarker-Guided Immunotherapies
    3. Others
2. Market Analysis, Insights and Forecast – By Cancer Type
  1. Breast Cancer
  2. Lung Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Hematologic Malignancies
  7. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Cancer Centres
  2. Diagnostic Laboratories
  3. Academic & Research Institutes
  4. Pharmaceutical & Biotechnology Companies
  5. Others
4. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Precision Oncology Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Diagnostics
    1. Companion Diagnostics
    2. Comprehensive Genomic Profiling
    3. Liquid Biopsy Assays
    4. Single Biomarker Tests
    5. Others
  2. Therapeutics
    1. Targeted Therapies
    2. Biomarker-Guided Immunotherapies
    3. Others
2. Market Analysis, Insights and Forecast – By Cancer Type
  1. Breast Cancer
  2. Lung Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Hematologic Malignancies
  7. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Cancer Centres
  2. Diagnostic Laboratories
  3. Academic & Research Institutes
  4. Pharmaceutical & Biotechnology Companies
  5. Others
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Precision Oncology Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Diagnostics
    1. Companion Diagnostics
    2. Comprehensive Genomic Profiling
    3. Liquid Biopsy Assays
    4. Single Biomarker Tests
    5. Others
  2. Therapeutics
    1. Targeted Therapies
    2. Biomarker-Guided Immunotherapies
    3. Others
2. Market Analysis, Insights and Forecast – By Cancer Type
  1. Breast Cancer
  2. Lung Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Hematologic Malignancies
  7. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Cancer Centres
  2. Diagnostic Laboratories
  3. Academic & Research Institutes
  4. Pharmaceutical & Biotechnology Companies
  5. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Precision Oncology Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Diagnostics
    1. Companion Diagnostics
    2. Comprehensive Genomic Profiling
    3. Liquid Biopsy Assays
    4. Single Biomarker Tests
    5. Others
  2. Therapeutics
    1. Targeted Therapies
    2. Biomarker-Guided Immunotherapies
    3. Others
2. Market Analysis, Insights and Forecast – By Cancer Type
  1. Breast Cancer
  2. Lung Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Hematologic Malignancies
  7. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Cancer Centres
  2. Diagnostic Laboratories
  3. Academic & Research Institutes
  4. Pharmaceutical & Biotechnology Companies
  5. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Precision Oncology Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Diagnostics
    1. Companion Diagnostics
    2. Comprehensive Genomic Profiling
    3. Liquid Biopsy Assays
    4. Single Biomarker Tests
    5. Others
  2. Therapeutics
    1. Targeted Therapies
    2. Biomarker-Guided Immunotherapies
    3. Others
2. Market Analysis, Insights and Forecast – By Cancer Type
  1. Breast Cancer
  2. Lung Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Hematologic Malignancies
  7. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Cancer Centres
  2. Diagnostic Laboratories
  3. Academic & Research Institutes
  4. Pharmaceutical & Biotechnology Companies
  5. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Precision Oncology Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Diagnostics
    1. Companion Diagnostics
    2. Comprehensive Genomic Profiling
    3. Liquid Biopsy Assays
    4. Single Biomarker Tests
    5. Others
  2. Therapeutics
    1. Targeted Therapies
    2. Biomarker-Guided Immunotherapies
    3. Others
2. Market Analysis, Insights and Forecast – By Cancer Type
  1. Breast Cancer
  2. Lung Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Hematologic Malignancies
  7. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Cancer Centres
  2. Diagnostic Laboratories
  3. Academic & Research Institutes
  4. Pharmaceutical & Biotechnology Companies
  5. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. F. Hoffmann-La Roche Ltd
  2. Guardant Health, Inc.
  3. TEMPUS
  4. Caris Life Sciences.
  5. Illumina Inc.
  6. QIAGEN
  7. Thermo Fisher Scientific Inc.
  8. AstraZeneca
  9. Novartis AG
  10. Myriad Genetics, Inc.

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Challenges
4. Market Opportunities
5. Market Trends
Key Insights
1. Technological Advancements in Precision Oncology
2. Regulatory Scenario, By Key Countries/Region
3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
4. New Product Launches, By Key Players
Global Precision Oncology Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Diagnostics
    1. Companion Diagnostics
    2. Comprehensive Genomic Profiling
    3. Liquid Biopsy Assays
    4. Single Biomarker Tests
    5. Others
  2. Therapeutics
    1. Targeted Therapies
    2. Biomarker-Guided Immunotherapies
    3. Others
2. Market Analysis, Insights and Forecast – By Cancer Type
  1. Breast Cancer
  2. Lung Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Hematologic Malignancies
  7. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Cancer Centres
  2. Diagnostic Laboratories
  3. Academic & Research Institutes
  4. Pharmaceutical & Biotechnology Companies
  5. Others
4. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Precision Oncology Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Diagnostics
    1. Companion Diagnostics
    2. Comprehensive Genomic Profiling
    3. Liquid Biopsy Assays
    4. Single Biomarker Tests
    5. Others
  2. Therapeutics
    1. Targeted Therapies
    2. Biomarker-Guided Immunotherapies
    3. Others
2. Market Analysis, Insights and Forecast – By Cancer Type
  1. Breast Cancer
  2. Lung Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Hematologic Malignancies
  7. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Cancer Centres
  2. Diagnostic Laboratories
  3. Academic & Research Institutes
  4. Pharmaceutical & Biotechnology Companies
  5. Others
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Precision Oncology Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Diagnostics
    1. Companion Diagnostics
    2. Comprehensive Genomic Profiling
    3. Liquid Biopsy Assays
    4. Single Biomarker Tests
    5. Others
  2. Therapeutics
    1. Targeted Therapies
    2. Biomarker-Guided Immunotherapies
    3. Others
2. Market Analysis, Insights and Forecast – By Cancer Type
  1. Breast Cancer
  2. Lung Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Hematologic Malignancies
  7. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Cancer Centres
  2. Diagnostic Laboratories
  3. Academic & Research Institutes
  4. Pharmaceutical & Biotechnology Companies
  5. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Precision Oncology Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Diagnostics
    1. Companion Diagnostics
    2. Comprehensive Genomic Profiling
    3. Liquid Biopsy Assays
    4. Single Biomarker Tests
    5. Others
  2. Therapeutics
    1. Targeted Therapies
    2. Biomarker-Guided Immunotherapies
    3. Others
2. Market Analysis, Insights and Forecast – By Cancer Type
  1. Breast Cancer
  2. Lung Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Hematologic Malignancies
  7. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Cancer Centres
  2. Diagnostic Laboratories
  3. Academic & Research Institutes
  4. Pharmaceutical & Biotechnology Companies
  5. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Precision Oncology Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Diagnostics
    1. Companion Diagnostics
    2. Comprehensive Genomic Profiling
    3. Liquid Biopsy Assays
    4. Single Biomarker Tests
    5. Others
  2. Therapeutics
    1. Targeted Therapies
    2. Biomarker-Guided Immunotherapies
    3. Others
2. Market Analysis, Insights and Forecast – By Cancer Type
  1. Breast Cancer
  2. Lung Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Hematologic Malignancies
  7. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Cancer Centres
  2. Diagnostic Laboratories
  3. Academic & Research Institutes
  4. Pharmaceutical & Biotechnology Companies
  5. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Precision Oncology Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Diagnostics
    1. Companion Diagnostics
    2. Comprehensive Genomic Profiling
    3. Liquid Biopsy Assays
    4. Single Biomarker Tests
    5. Others
  2. Therapeutics
    1. Targeted Therapies
    2. Biomarker-Guided Immunotherapies
    3. Others
2. Market Analysis, Insights and Forecast – By Cancer Type
  1. Breast Cancer
  2. Lung Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Melanoma
  6. Hematologic Malignancies
  7. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Cancer Centres
  2. Diagnostic Laboratories
  3. Academic & Research Institutes
  4. Pharmaceutical & Biotechnology Companies
  5. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. F. Hoffmann-La Roche Ltd
  2. Guardant Health, Inc.
  3. TEMPUS
  4. Caris Life Sciences.
  5. Illumina Inc.
  6. QIAGEN
  7. Thermo Fisher Scientific Inc.
  8. AstraZeneca
  9. Novartis AG
  10. Myriad Genetics, Inc.

Read Less

List of Figures

Figure 1: Global Precision Oncology Market Revenue Breakdown (USD billion) By Region, 2025 & 2034

Figure 2: Global Precision Oncology Market Value Share (%), By Type, 2025 & 2034

Figure 3: Global Precision Oncology Market Value Share (%), By Cancer Type, 2025 & 2034

Figure 4: Global Precision Oncology Market Value Share (%), By End User, 2025 & 2034

Figure 5: Global Precision Oncology Market Value Share (%), By Region, 2025 & 2034

Figure 6: North America Precision Oncology Market Value (USD billion), By Type, 2025 & 2034

Figure 7: North America Precision Oncology Market Value Share (%), By Type, 2025

Figure 8: North America Precision Oncology Market Value (USD billion), By Cancer Type, 2025 & 2034

Figure 9: North America Precision Oncology Market Value Share (%), By Cancer Type, 2025

Figure 10: North America Precision Oncology Market Value (USD billion), By End User, 2025 & 2034

Figure 11: North America Precision Oncology Market Value Share (%), By End User, 2025

Figure 12: North America Precision Oncology Market Value (USD billion), By Country, 2025 & 2034

Figure 13: North America Precision Oncology Market Value Share (%), By Country, 2025

Figure 14: Europe Precision Oncology Market Value (USD billion), By Type, 2025 & 2034

Figure 15: Europe Precision Oncology Market Value Share (%), By Type, 2025

Figure 16: Europe Precision Oncology Market Value (USD billion), By Cancer Type, 2025 & 2034

Figure 17: Europe Precision Oncology Market Value Share (%), By Cancer Type, 2025

Figure 18: Europe Precision Oncology Market Value (USD billion), By End User, 2025 & 2034

Figure 19: Europe Precision Oncology Market Value Share (%), By End User, 2025

Figure 20: Europe Precision Oncology Market Value (USD billion), By Country/Sub-region, 2025 & 2034

Figure 21: Europe Precision Oncology Market Value Share (%), By Country/Sub-region, 2025

Figure 22: Asia Pacific Precision Oncology Market Value (USD billion), By Type, 2025 & 2034

Figure 23: Asia Pacific Precision Oncology Market Value Share (%), By Type, 2025

Figure 24: Asia Pacific Precision Oncology Market Value (USD billion), By Cancer Type, 2025 & 2034

Figure 25: Asia Pacific Precision Oncology Market Value Share (%), By Cancer Type, 2025

Figure 26: Asia Pacific Precision Oncology Market Value (USD billion), By End User, 2025 & 2034

Figure 27: Asia Pacific Precision Oncology Market Value Share (%), By End User, 2025

Figure 28: Asia Pacific Precision Oncology Market Value (USD billion), By Country/Sub-region, 2025 & 2034

Figure 29: Asia Pacific Precision Oncology Market Value Share (%), By Country/Sub-region, 2025

Figure 30: Latin America Precision Oncology Market Value (USD billion), By Type, 2025 & 2034

Figure 31: Latin America Precision Oncology Market Value Share (%), By Type, 2025

Figure 32: Latin America Precision Oncology Market Value (USD billion), By Cancer Type, 2025 & 2034

Figure 33: Latin America Precision Oncology Market Value Share (%), By Cancer Type, 2025

Figure 34: Latin America Precision Oncology Market Value (USD billion), By End User, 2025 & 2034

Figure 35: Latin America Precision Oncology Market Value Share (%), By End User, 2025

Figure 36: Latin America Precision Oncology Market Value (USD billion), By Country/Sub-region, 2025 & 2034

Figure 37: Latin America Precision Oncology Market Value Share (%), By Country/Sub-region, 2025

Figure 38: Middle East & Africa Precision Oncology Market Value (USD billion), By Type, 2025 & 2034

Figure 39: Middle East & Africa Precision Oncology Market Value Share (%), By Type, 2025

Figure 40: Middle East & Africa Precision Oncology Market Value (USD billion), By Cancer Type, 2025 & 2034

Figure 41: Middle East & Africa Precision Oncology Market Value Share (%), By Cancer Type, 2025

Figure 42: Middle East & Africa Precision Oncology Market Value (USD billion), By End User, 2025 & 2034

Figure 43: Middle East & Africa Precision Oncology Market Value Share (%), By End User, 2025

Figure 44: Middle East & Africa Precision Oncology Market Value (USD billion), By Country/Sub-region, 2025 & 2034

Figure 45: Middle East & Africa Precision Oncology Market Value Share (%), By Country/Sub-region, 2025

Figure 46: Global Precision Oncology Market Share (%), By Company, 2025

List of Tables

Table 1: Global Precision Oncology Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 2: Global Precision Oncology Market Revenue (USD billion) Forecast, By Diagnostics, 2021-2034

Table 3: Global Precision Oncology Market Revenue (USD billion) Forecast, By Therapeutics, 2021-2034

Table 4: Global Precision Oncology Market Revenue (USD billion) Forecast, By Cancer Type, 2021-2034

Table 5: Global Precision Oncology Market Revenue (USD billion) Forecast, By End User, 2021-2034

Table 6: Global Precision Oncology Market Revenue (USD billion) Forecast, By Region, 2021-2034

Table 7: North America Precision Oncology Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 8: North America Precision Oncology Market Revenue (USD billion) Forecast, By Diagnostics, 2021-2034

Table 9: North America Precision Oncology Market Revenue (USD billion) Forecast, By Therapeutics, 2021-2034

Table 10: North America Precision Oncology Market Revenue (USD billion) Forecast, By Cancer Type, 2021-2034

Table 11: North America Precision Oncology Market Revenue (USD billion) Forecast, By End User, 2021-2034

Table 12: North America Precision Oncology Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 13: Europe Precision Oncology Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 14: Europe Precision Oncology Market Revenue (USD billion) Forecast, By Diagnostics, 2021-2034

Table 15: Europe Precision Oncology Market Revenue (USD billion) Forecast, By Therapeutics, 2021-2034

Table 16: Europe Precision Oncology Market Revenue (USD billion) Forecast, By Cancer Type, 2021-2034

Table 17: Europe Precision Oncology Market Revenue (USD billion) Forecast, By End User, 2021-2034

Table 18: Europe Precision Oncology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 19: Asia Pacific Precision Oncology Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 20: Asia Pacific Precision Oncology Market Revenue (USD billion) Forecast, By Diagnostics, 2021-2034

Table 21: Asia Pacific Precision Oncology Market Revenue (USD billion) Forecast, By Therapeutics, 2021-2034

Table 22: Asia Pacific Precision Oncology Market Revenue (USD billion) Forecast, By Cancer Type, 2021-2034

Table 23: Asia Pacific Precision Oncology Market Revenue (USD billion) Forecast, By End User, 2021-2034

Table 24: Asia Pacific Precision Oncology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 25: Latin America Precision Oncology Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 26: Latin America Precision Oncology Market Revenue (USD billion) Forecast, By Diagnostics, 2021-2034

Table 27: Latin America Precision Oncology Market Revenue (USD billion) Forecast, By Therapeutics, 2021-2034

Table 28: Latin America Precision Oncology Market Revenue (USD billion) Forecast, By Cancer Type, 2021-2034

Table 29: Latin America Precision Oncology Market Revenue (USD billion) Forecast, By End User, 2021-2034

Table 30: Latin America Precision Oncology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 31: Middle East & Africa Precision Oncology Market Revenue (USD billion) Forecast, By Type, 2021-2034

Table 32: Middle East & Africa Precision Oncology Market Revenue (USD billion) Forecast, By Diagnostics, 2021-2034

Table 33: Middle East & Africa Precision Oncology Market Revenue (USD billion) Forecast, By Therapeutics, 2021-2034

Table 34: Middle East & Africa Precision Oncology Market Revenue (USD billion) Forecast, By Cancer Type, 2021-2034

Table 35: Middle East & Africa Precision Oncology Market Revenue (USD billion) Forecast, By End User, 2021-2034

Table 36: Middle East & Africa Precision Oncology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 198

Buy Now

Download Free Sample

Security Code

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

(APAC) +91 744 740 1245
sales@fortunebusinessinsights.com